Literature DB >> 28192577

Diagnosing Acute HIV Infection.

Paul Devine Bottone, Allison H Bartlett.   

Abstract

Acute HIV infection (AHI) represents the first 6 to 12 weeks of the disease process, when the virus is aggressively replicating in the lymphoid tissues. Accordingly, high viral loads are often present during this phase, with declining lymphocyte levels, as the CD4+ T-cell subset is preferentially commandeered to facilitate viral reproduction. Detection at this stage is imperative-the affected are often unaware, but highly infectious. Unfortunately, correct diagnosis of AHI can be challenging because the more traditional, frequently used tests, which rely on antibody detection, will often produce false-negative results during the "window period" (usually 3 to 4 weeks from infection) due to slow production of HIV antibodies. Consequently, testing with fourth-generation antibody-antigen and viral nucleic acid polymerase chain reaction modalities, which can yield positive results within 5 to 7 days of infection, is vital in the context of any significant concern for AHI. [Pediatr Ann. 2017;46(2):e47-e50.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28192577     DOI: 10.3928/19382359-20170118-01

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  2 in total

1.  Brazilian Protocol for Sexually Transmitted Infections, 2020: HIV infection in adolescents and adults.

Authors:  Lauro Ferreira da Silva Pinto Neto; Filipe de Barros Perini; Mayra Gonçalves Aragón; Marcelo Araújo Freitas; Angélica Espinosa Miranda
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

2.  Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range.

Authors:  Colleen N Loynachan; Michael R Thomas; Eleanor R Gray; Daniel A Richards; Jeongyun Kim; Benjamin S Miller; Jennifer C Brookes; Shweta Agarwal; Vijay Chudasama; Rachel A McKendry; Molly M Stevens
Journal:  ACS Nano       Date:  2017-12-22       Impact factor: 15.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.